Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 16,682 shares at $69.89 ($1.2M) on 2025-10-06, disclosed to the SEC on 2025-10-08.
Scheduled sale ($1.2M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.27 | 3,241 | $225K | 19.3% |
| 2 | $69.27 | 3,241 | $225K | 19.3% |
| 3 | $69.89 | 10,200 | $713K | 61.4% |
| Total | $69.65 avg | 16,682 | $1.2M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-02 | $8.8M | — | Filing → |